0.742
price up icon6.13%   0.041
 
loading
Schlusskurs vom Vortag:
$0.701
Offen:
$0.691
24-Stunden-Volumen:
363.66K
Relative Volume:
0.34
Marktkapitalisierung:
$54.56M
Einnahmen:
$11.03M
Nettoeinkommen (Verlust:
$-44.24M
KGV:
-1.1968
EPS:
-0.62
Netto-Cashflow:
$-42.61M
1W Leistung:
-6.74%
1M Leistung:
-23.30%
6M Leistung:
-26.34%
1J Leistung:
-23.30%
1-Tages-Spanne:
Value
$0.691
$0.7685
1-Wochen-Bereich:
Value
$0.6797
$0.7977
52-Wochen-Spanne:
Value
$0.6797
$1.90

Hyperfine Inc Stock (HYPR) Company Profile

Name
Firmenname
Hyperfine Inc
Name
Telefon
866-796-6767
Name
Adresse
351 NEW WHITFIELD STREET, GUILFORD
Name
Mitarbeiter
111
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
HYPR's Discussions on Twitter

Vergleichen Sie HYPR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
HYPR
Hyperfine Inc
0.7423 54.56M 11.03M -44.24M -42.61M -0.62
Medical Devices icon
ABT
Abbott Laboratories
131.69 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.75 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
374.75 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.62 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.08 42.10B 5.72B 4.17B 259.90M 6.97

Hyperfine Inc Stock (HYPR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-08-11 Herabstufung Wells Fargo Overweight → Equal Weight
2022-05-31 Eingeleitet Evercore ISI Outperform
2022-04-14 Eingeleitet Wells Fargo Overweight

Hyperfine Inc Aktie (HYPR) Neueste Nachrichten

pulisher
Mar 25, 2025

Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN

Mar 25, 2025
pulisher
Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Hyperfine initiated with a Buy at Lake Street - TipRanks

Mar 24, 2025
pulisher
Mar 22, 2025

What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash - Simply Wall St

Mar 22, 2025
pulisher
Mar 20, 2025

Hyperfine price target lowered to $1.20 from $1.50 at B. Riley - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

B. Riley Trims Price Target on Hyperfine to $1.20 From $1.50, Keeps Buy Rating -March 20, 2025 at 07:57 am EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView

Mar 20, 2025
pulisher
Mar 19, 2025

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

Hyperfine Inc. Faces Potential Stock Price Decline Amid $150 Million Securities Sale Plan - TipRanks

Mar 19, 2025
pulisher
Mar 18, 2025

Hyperfine Inc. Earnings Call: Growth Amid Challenges - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Hyperfine teams up with NVIDIA to enhance AI-powered portable MR - DOTmed HealthCare Business News

Mar 18, 2025
pulisher
Mar 18, 2025

Hyperfine reports net loss of USD 10.39M in Q4 2024 - Medical Buyer

Mar 18, 2025
pulisher
Mar 18, 2025

Hyperfine Inc (HYPR) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

NVIDIA partners with Hyperfine on Swoop MRI AI system - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings call transcript: Hyperfine Q4 2024 reports mixed results By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

Hyperfine, Inc. Reports 2024 Financial Results and Strategic Expansion - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

Earnings call transcript: Hyperfine Q4 2024 reports mixed results - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine earnings matched, revenue fell short of estimates - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine shares tumble as Q4 revenue misses estimates By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine shares tumble as Q4 revenue misses estimates - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

HYPERFINE Earnings Results: $HYPR Reports Quarterly Earnings - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine reports Q4 EPS (14c), consensus (14c) - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation - 01net

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, NVIDIA Partner to Transform Neuroimaging with AI - MPO-mag

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine Collaborating With Nvidia to Improve Portable MRI Technology; Shares Jump - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine partners with NVIDIA to enhance portable MRI tech - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine partners with NVIDIA to enhance portable MRI tech By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Revolutionary AI Partnership: How Hyperfine and NVIDIA Are Making Brain MRI Available to Billions - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

Earnings Scheduled For March 17, 2025 - Benzinga

Mar 17, 2025
pulisher
Mar 10, 2025

Hyperfine (HYPR) Projected to Post Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 04, 2025

When Will Portable MRI Pioneer Hyperfine Reveal Its 2024 Performance? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 - Business Wire

Mar 04, 2025
pulisher
Feb 20, 2025

Insider Selling: TEISSEYRE THOMAS, Hyperfine Inc [HYPR] Chief Operating Officer divested 3,237 shares - Knox Daily

Feb 20, 2025
pulisher
Feb 18, 2025

Hyperfine COO Thomas Teisseyre sells $3,884 in stock By Investing.com - Investing.com Australia

Feb 18, 2025
pulisher
Feb 18, 2025

Hyperfine COO Thomas Teisseyre sells $3,884 in stock - Investing.com India

Feb 18, 2025
pulisher
Feb 17, 2025

Hyperfine reports growing evidence supporting use of Swoop system images in stroke diagnosis - NeuroNews International

Feb 17, 2025
pulisher
Feb 13, 2025

Hyperfine stock tumbles after direct offering announcement - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Hyperfine announces registered direct offering - Medical Buyer

Feb 12, 2025
pulisher
Feb 12, 2025

Hyperfine announces $6 million direct offering - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Hyperfine looks to raise $6M in direct offering, stock tumbles - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Hyperfine Announces $6.0 Million Registered Direct Offering - citybiz

Feb 11, 2025

Finanzdaten der Hyperfine Inc-Aktie (HYPR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Hyperfine Inc-Aktie (HYPR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
TEISSEYRE THOMAS
Chief Operating Officer
Nov 18 '24
Sale
0.85
2,800
2,380
88,227
TEISSEYRE THOMAS
Chief Operating Officer
Aug 16 '24
Sale
1.05
2,746
2,883
91,027
TEISSEYRE THOMAS
Chief Operating Officer
May 16 '24
Sale
0.88
2,753
2,423
93,773
medical_devices STE
$227.62
price up icon 0.80%
medical_devices ZBH
$112.47
price up icon 0.09%
medical_devices PHG
$24.92
price down icon 1.17%
$67.12
price down icon 0.77%
$79.03
price down icon 0.72%
medical_devices EW
$72.21
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):